Dashboard
Manage Tickers

BDTX Black Diamond Therapeutics,...

Nasdaq blackdiamondtherapeutics.com


$ 3.99 $ -0.17 (-4.07 %)    

Friday, 17-Oct-2025 18:31:13 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 4.01
$ 4.12
$ 3.72 x 2,500
$ 4.18 x 20
$ 3.88 - $ 4.17
$ 1.20 - $ 4.45
875,569
na
228.31M
$ 2.34
$ 15.81
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-12-2025 03-31-2025 10-Q
3 03-06-2025 01-01-1970 10-K
4 11-05-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-12-2024 12-31-2023 10-K
8 11-06-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-09-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-11-2022 03-31-2022 10-Q
15 03-17-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-07-2021 03-31-2021 10-Q
19 03-25-2021 12-31-2020 10-K
20 11-10-2020 09-30-2020 10-Q
21 08-11-2020 06-30-2020 10-Q
22 05-12-2020 03-31-2020 10-Q
23 03-24-2020 12-31-2019 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stifel-reinstates-buy-on-black-diamond-therapeutic-announces-8-price-target
Stifel Reinstates Buy on Black Diamond The...
10/16/2025 13:50:09

Stifel analyst Laura Prendergast reinstates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and announces $8 price target.

4-biotechnology-stocks-lead-momentum-gains-amid-strong-technicals
4 Biotechnology Stocks Lead Momentum Gains...
10/10/2025 08:32:04

4 biotech stocks—ALDX, ALEC, BDTX, CHRS—show strong week-on-week momentum ranking gains and improving technical indicators.

guggenheim-initiates-coverage-on-black-diamond-therapeutic-with-buy-rating-announces-price-target-of-8
Guggenheim Initiates Coverage On Black Dia...
09/04/2025 13:58:44

Guggenheim analyst Brad Canino initiates coverage on Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy rating and announces...

hc-wainwright--co-maintains-buy-on-black-diamond-therapeutic-lowers-price-target-to-10
HC Wainwright & Co. Maintains Buy on Black...
08/11/2025 10:33:58

HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and lowers the pri...

black-diamond-therapeutic-q2-eps-019-beats-022-estimate
Black Diamond Therapeutic Q2 EPS $(0.19) B...
08/07/2025 11:55:25

raymond-james-reinstates-outperform-on-black-diamond-therapeutic-announces-11-price-target
Raymond James Reinstates Outperform on Bla...
07/01/2025 15:39:17

Raymond James analyst Sean McCutcheon reinstates Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform and announces $11...

black-diamond-therapeutic-q1-eps-098-beats-002-estimate-sales-7000m
Black Diamond Therapeutic Q1 EPS $0.98 Bea...
05/12/2025 20:38:34

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimat...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
03/19/2025 17:06:05

black-diamond-therapeutics-inks-licensing-pact-with-french-pharma-firm-servier-for-its-early-stage-cancer-drug-worth-over-700-million
Black Diamond Therapeutics Inks Licensing ...
03/19/2025 14:45:41

Servier announces a strategic worldwide licensing agreement for Black Diamond Therapeutics' BDTX-4933 for solid tumors for ...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
03/19/2025 12:07:12

Core News & Articles
Market-Moving News for March 19th
03/19/2025 11:23:47

SIG: 18% | Signet Jewelers shares are trading higher after the company reported better-than-expected Q4 adjusted EPS and sales....

black-diamond-therapeutics-and-servier-announce-a-global-licensing-agreement-for-bdtx-4933-for-solid-tumors-servier-will-develop-and-commercialize-bdtx-4933-black-diamond-to-receive-70m-upfront-payment-and-up-to-710m-in-milestones
Black Diamond Therapeutics And Servier Ann...
03/19/2025 11:04:52

hc-wainwright--co-maintains-buy-on-black-diamond-therapeutic-raises-price-target-to-12
HC Wainwright & Co. Maintains Buy on Black...
03/18/2025 11:26:48

HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and raises the pri...

stifel-maintains-buy-on-black-diamond-therapeutic-lowers-price-target-to-15
Stifel Maintains Buy on Black Diamond Ther...
03/07/2025 16:43:11

Stifel analyst Bradley Canino maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and lowers the price target from ...

black-diamond-therapeutic-q4-eps-028-beats-031-estimate
Black Diamond Therapeutic Q4 EPS $(0.28) B...
03/06/2025 21:03:39

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimat...

why-sage-therapeutics-shares-are-trading-higher-by-over-34-here-are-20-stocks-moving-premarket
Why Sage Therapeutics Shares Are Trading H...
01/13/2025 10:45:28

hc-wainwright--co-reiterates-buy-on-black-diamond-therapeutic-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Blac...
11/06/2024 09:49:29

HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and maintains $11...

black-diamond-therapeutics-cash-cash-equivalents-and-investments-of-1127m-as-of-september-30-2024-expected-to-be-sufficient-to-fund-operations-into-q2-of-2026
Black Diamond Therapeutic's Cash, Cash Equ...
11/05/2024 12:10:52

black-diamond-therapeutic-q3-2024-gaap-eps-028-beats-038-estimate
Black Diamond Therapeutic Q3 2024 GAAP EPS...
11/05/2024 12:10:32

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimat...

hc-wainwright--co-reiterates-buy-on-black-diamond-therapeutic-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Blac...
10/09/2024 10:58:16

HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and maintains $11...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION